Trial Profile
A Phase II Study of Reduced Intensity Allogeneic Bone Marrow Transplantation for the Treatment of Relapsed Non-Hodgkin and Hodgkin Lymphoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Pentostatin (Primary) ; Ciclosporin; Ciclosporin; Methotrexate; Methoxsalen; Mycophenolate mofetil; Tacrolimus
- Indications Hodgkin's disease; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 22 Oct 2007 Status changed from recruiting to in progress.
- 19 Nov 2005 New trial record.